Compound Name (alphabetical) | Enz. Inhib. Data | ITC Data | Binding Targets | Alternate Compound Names |
---|
Ki | IC50 | Kd | EC50 | Koff | Kon | Other |
---|
BDBM101536
 | 5 | 7 | 0 | 1 | 0 | 0 | 0 | 0 | - CDK7/Cyclin H/MNAT1
- PAK 1/CDC42
- Serine/threonine-protein kinase PAK 4
| - CHEMBL3128043
- US8530494, 203
- US8530652, 114
- US8530652, 63
|
BDBM102619
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - ALK1
- ALK2
- ALK3
- ALK4
- ALK5
- Activin receptor type-1
- TGF-beta receptor type-1
- Tyrosine-protein kinase Fyn
| - K02288a
- US10688093, Compound 382_0087_0284
|
BDBM10512
 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Acetylcholinesterase
- Beta amyloid A4 protein
- Cholinesterases
| - CHEMBL194823
- N-{3-[(6-chloro-1,2,3,4-tetrahydroacridin-9-yl)amino]propyl}-5-(1,2-dithiolan-3-yl)pentanamide
- tacrine-lipoic acid hybrid 7
|
BDBM10527
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Caspase-1
- Caspase-3
- Caspase-7
- Caspase-8
| - (3S)-5-(benzylsulfanyl)-3-[(2S)-2-[1-(5-bromo-2-methoxyphenyl)acetamido]-3-methylbutanamido]-4-oxopentanoic acid
- BROMOMETHOXYPHENYL INHIBITOR
- valine aspartyl ketone 29
- valine aspartyl ketone 6
- valine aspartyl ketone analog 10
|
BDBM106699
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 5-hydroxytryptamine 1D receptor (5HT1D)
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Nitric oxide synthase, brain
- Nitric oxide synthase, endothelial
- Nitric oxide synthase, inducible
- Nitric-oxide synthase, brain
| - CHEMBL1957350
- US8586620, 46
|
BDBM107487
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 11-beta-hydroxysteroid dehydrogenase
- 11-beta-hydroxysteroid dehydrogenase 1
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 3A
| - US8575157, 201
- US8592410, Comparator 13
- US8598163, 71
|
BDBM107698
 | 0 | 10 | 0 | 3 | 0 | 0 | 0 | 0 | - Egl nine homolog 1
- Prolyl hydroxylase EGLN3
- Vascular endothelial growth factor A
| - US8598210, Table XV, 4
- US8722895, 4: [(3-Hydroxy-5-(4-methylphenyl)pyridine-2- carbonyl)amino]-acetic acid
- US9598370, Example 00129
- USRE47437, Example [(3-Hydroxy-5-(4-methylphenyl)pyridine-2-carbonyl)amino]-acetic acid
|
BDBM10826
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Acetylcholinesterase
- Amine oxidase (flavin-containing) A
- Amine oxidase [flavin-containing] B
- Butyrylcholinesterase (BChE)
- Cholinesterase
- Monoamine Oxidase Type B (MAO-B)
- Monoamine oxidase
| - 3-{2-[methyl(prop-2-yn-1-yl)amino]propyl}phenyl N-hexyl-N-methylcarbamate
- CHEMBL356385
- Phenethylamine deriv. 53d
|
BDBM10840
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 3-phosphoinositide dependent protein kinase-1
- Axin-1/Glycogen synthase kinase-3 beta
- Casein Kinase I
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 5 (CDK5)
- Dual specificty protein kinase CLK1
- Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
- Glycogen Synthase Kinase-3, beta
- Serine/threonine-protein kinase pim-1
- cAMP-Dependent Protein Kinase (PKA)
- cGMP-Dependent Protein Kinase
| - 4-(5-bromo-1H-indol-3-yl)pyrimidin-2-amine
- Meridianin C
|
BDBM10853
 | 1 | 5 | 7 | 0 | 0 | 0 | 0 | 0 | - Chitinase (chiA1)
- Chitinase 1
- Chitinase B
- Chitinase Mutant (A217G)
- Chitinase Mutant (D175A)
- Chitinase Mutant (E322A)
- Chitinase Mutant (M243A)
- Chitinase Mutant (R301K)
- Chitinase Mutant (T138A)
- Endochitinase B1
| - (2R,5S,8S,11S,15S)-8-benzyl-2,7-dimethyl-5-[3-({[(methylcarbamoyl)amino]methanimidoyl}amino)propyl]-3,6,9,13,17-pentaoxo-1,4,7,10,14-pentaazacycloheptadecane-11,15-dicarboxylic acid
- Argifin
|
BDBM11337
 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Carbonic Anhydrase IV
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Collagenase (ChC)
- Interstitial collagenase
- Matrix metalloproteinase 12
- Matrix metalloproteinase-9
- Neutrophil collagenase
- Stromelysin-1
| - 2-[benzyl(4-methoxybenzene)sulfonamido]-N-hydroxypropanamide
- CHEMBL316169
- Hydroxamate 18
|
BDBM11548
 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Collagenase 3
- Disintegrin and metalloproteinase domain-containing protein 17
- Interstitial collagenase
- Matrix metalloproteinase-9
| - CHEMBL100570
- N-hydroxy-2-[(4-methoxy-1,1-biphenyl-4-yl)methyl]isothiazolidine-3-carboxamide 1,1-dioxide
- N-hydroxy-2-{[4-(4-methoxyphenyl)phenyl]methyl}-1,1-dioxo-1,2-thiazolidine-3-carboxamide
- Sultam Hydroxamate 15a
|
BDBM116247
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Beta-secretase 2
- IDH1 R132H
| - US10035794, Example 24
- US10683287, Example 35
- US8637508, 24
|
BDBM120086
 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Dual specificity mitogen-activated protein kinase kinase 1/Mitogen-activated protein kinase 1/RAF proto-oncogene serine/threonine-protein kinase
- MAP kinase ERK1
- Mitogen-activated protein kinase 1
- Potassium voltage-gated channel subfamily H member 2
| |
BDBM12028
 | 2 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - CDK2/CycE
- CDK2/Cyclin A/Cyclin A1
- Cyclin-Dependent Kinase 1 (CDK1)
- Cyclin-Dependent Kinase 2 (CDK2)
- Cyclin-Dependent Kinase 4 (CDK4)
- Cyclin-Dependent Kinase 7 (CDK7)
- Cyclin-Dependent Kinase 9 (CDK9)
- Cyclin-dependent kinase 1
- Cyclin-dependent kinase 2
- Cyclin-dependent kinase 4
- Cyclin-dependent kinase 7
- Cyclin-dependent kinase 9
| - 4-Arylazo-3,5-diamino-1H-pyrazole 31b
- 4-[(E)-2-(3,5-diamino-1H-pyrazol-4-yl)diazen-1-yl]phenol
- CAN508
|
BDBM12075
 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - 72 kDa type IV collagenase
- Collagenase 3
- Interstitial collagenase
- Matrix metalloproteinase-14 (MMP14)
- Matrix metalloproteinase-7 (MMP7)
- Matrix metalloproteinase-9
- Stromelysin-1
| - (2S)-2-{[4-(4-bromophenyl)benzene]sulfonamido}-3-methylbutanoic acid
- CHEMBL43152
- alpha-arylsulfonylamino carboxylate 2S
|
BDBM123327
 | 4 | 5 | 4 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Orexin receptor type 1
- Orexin receptor type 2
- Potassium voltage-gated channel subfamily H member 2
| |
BDBM12352
 | 3 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - Alkaline phosphatase, tissue-nonspecific isozyme
- Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - 3-(1-methyl-1H-imidazol-4-yl)pyridine
- CHEMBL360999
- US8609708, 5
- cid_11344157
- nicotine 3-heteroaromatic analogue 5
|
BDBM12356
 | 3 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - Alkaline phosphatase, tissue-nonspecific isozyme
- Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - 3-(2-methyl-1H-imidazol-1-yl)pyridine
- CHEMBL368883
- US8609708,13
- cid_16654686
- nicotine 3-heteroaromatic analogue 9
|
BDBM12358
 | 3 | 10 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2A6
- Cytochrome P450 2B6
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 2E1
- Cytochrome P450 3A
| - 3-(4-methylthiophen-3-yl)pyridine
- CHEMBL179704
- US8609708, 17
- US8609708,17
- nicotine 3-heteroaromatic analogue 11
|
BDBM12577
 | 3 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - Farnesyl Diphosphate Synthase (FPPS)
- Farnesyl diphosphate synthase
- Geranylgeranyl Diphosphate Synthase (GGPPS)
- Squalene synthetase
| - Bisphosphonate 2
- CHEMBL997
- JMC515594 Compound 53
- {1-hydroxy-3-[methyl(pentyl)amino]-1-phosphonopropyl}phosphonic acid
|
BDBM13054
 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic Anhydrase VA
- Carbonic Anhydrase VB
- Carbonic Anhydrase XIII
- Carbonic Anhydrase XIV
- Carbonic anhydrase 1
- Carbonic anhydrase 12
- Carbonic anhydrase 2
- Carbonic anhydrase 4
- Carbonic anhydrase 6 (CA-VI)
- Carbonic anhydrase 7
- Carbonic anhydrase 9
| - (2R,4R)-4-(ethylamino)-2-methyl-1,1-dioxo-2H,3H,4H-1,7-thieno[2,3-b]thiopyran-6-sulfonamide
- Dorzolamide, DZA
- sulfonamide 5
|
BDBM130903
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- Fibroblast growth factor receptor 1
- Fibroblast growth factor receptor 2
- Fibroblast growth factor receptor 3
- Fibroblast growth factor receptor 4
- Proto-oncogene tyrosine-protein kinase Src
- Vascular endothelial growth factor receptor 2
| - US10689705, Compound 7
- US8829199, 196
|
BDBM130906
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- Fibroblast growth factor receptor 1
- Fibroblast growth factor receptor 2
- Fibroblast growth factor receptor 3
- Fibroblast growth factor receptor 4
- Proto-oncogene tyrosine-protein kinase Src
- Vascular endothelial growth factor receptor 2
| - US10689705, Compound 46
- US8829199, 200
|
BDBM130909
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - BDNF/NT-3 growth factors receptor
- CDK2/CycE
- Cyclin-Dependent Kinase 4 (CDK4)
- Hepatocyte growth factor receptor
- High affinity nerve growth factor receptor
- Insulin receptor
- Insulin-like growth factor I receptor
- Mitogen-activated protein kinase kinase kinase 5
- NT-3 growth factor receptor
- Proto-oncogene tyrosine-protein kinase ROS
- Proto-oncogene tyrosine-protein kinase receptor Ret
- Receptor tyrosine-protein kinase erbB-2
- Serine/threonine-protein kinase receptor R3
| - US10683289, Example Staurosporine
- US10927120, Compound staurosporine
- US8822500, Stauro- sporine
- US9920060, Staurosporine
|
BDBM13280
 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Trypsin II
- Trypsin-1
- Vitamin K-dependent protein C
| - 3-{[(3S)-3-[(7-methoxynaphthalene-2-)sulfonamido]-2-oxopyrrolidin-1-yl]methyl}benzene-1-carboximidamide
- CHEMBL327600
- Sulfonamidopyrrolidinone 3a
|
BDBM14150
 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Trypsin-1
- Urokinase (uPA) Mutant (S190A)
- Urokinase-type plasminogen activator
| - APC-11417
- CA-12
- CRA-11417
- {amino[6-fluoro-2-(2-hydroxy-3-phenylphenyl)-1H-indol-5-yl]methylidene}azanium
|
BDBM14155
 | 11 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | - Coagulation factor X
- Kallikrein 1
- Kallikrein 5
- Plasminogen
- Prothrombin
- Tissue-type plasminogen activator
- Trypsin
- Urokinase-type plasminogen activator
| - APC-7136
- CHEMBL64708
- N-(4-CARBAMIMIDOYL-PHENYL)-2-HYDROXY-BENZAMIDE
- N-(4-carbamimidoylphenyl)-2-hydroxybenzamide
|
BDBM143218
 | 6 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Beta-secretase 2
- Cathepsin D
| - US8940748, 34
- US9029362, 34
- US9687494, 34
|
BDBM143362
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 3A
- Fatty-acid amide hydrolase 1
- Fatty-acid amide hydrolase 1 (aa 30-579)
| |
BDBM14773
 | 2 | 11 | 0 | 0 | 0 | 0 | 0 | 0 | - Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B
- Phosphodiesterase 8
- Phosphodiesterase Type 10 (PDE10A)
- Phosphodiesterase Type 11 (PDE11A)
- Phosphodiesterase Type 2 (PDE2A)
- Phosphodiesterase Type 3 (PDE3B)
- Phosphodiesterase Type 4 (PDE4B)
- Phosphodiesterase Type 4 (PDE4D)
- Phosphodiesterase Type 5 (PDE5A)
- Phosphodiesterase Type 7 (PDE7B)
- Phosphodiesterase Type 9 (PDE9A)
- cAMP-specific 3',5'-cyclic phosphodiesterase 4B
| - 4-cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)cyclohexane-1-carboxylic acid
- 4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid
- Ariflo
- Cilomilast
- SB207499
|
BDBM148176
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Beta-secretase 1
- Beta-secretase 2
- Cathepsin D
- Cytochrome P450 1A
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Potassium voltage-gated channel subfamily H member 2
| - US8962616, 22
- US8962616, 4
|
BDBM15148
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - RAC-alpha serine/threonine-protein kinase
- Serine/threonine-protein kinase AKT
- Serine/threonine-protein kinase AKT2
- Serine/threonine-protein kinase Sgk1
| - 2,3-diphenylquinoxaline 1
- 2-[4-(3-phenylquinoxalin-2-yl)phenyl]propan-2-amine
|
BDBM15222
 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - Carbonic Anhydrase VA
- Carbonic Anhydrase VB
- Carbonic anhydrase 1
- Carbonic anhydrase 2
- Carbonic anhydrase 9
| - 4-Azidobenzenesulfonamide
- 4-azidobenzene-1-sulfonamide
- CHEMBL222837
- azide 1
|
BDBM152692
 | 0 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Cereblon/Histone deacetylase 6
- Histone deacetylase
- Histone deacetylase 1
- Histone deacetylase 10
- Histone deacetylase 11
- Histone deacetylase 2
- Histone deacetylase 3
- Histone deacetylase 8
- Histone deacetylase 8 (HDAC8)
| |
BDBM155255
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 1A
- Cytochrome P450 1A1
- Cytochrome P450 2C19
- Cytochrome P450 2C8
- Cytochrome P450 2C9
- Cytochrome P450 2D6
- Cytochrome P450 2D6 (2D6)
- H3K27me2
- H3K27me3
- Histone-lysine N-methyltransferase EZH2
| - US10098888, Compound 105
- US9006242, 105
|
BDBM160075
 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | - Cytochrome P450 2C19
- P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
- P2X7 rat
- Potassium voltage-gated channel subfamily H member 2
| - US10047092, 16
- US9040534, 16
|
BDBM160130
 | 5 | 8 | 0 | 0 | 0 | 0 | 0 | 0 | - P2X purinoceptor 7
- P2X purinoceptor 7 (P2X7)
- P2X7 rat
| - US10047092, 72
- US10053463, 72
- US9040534, 71
- US9040534, 72
|
BDBM162872
 | 0 | 13 | 0 | 0 | 0 | 0 | 0 | 0 | - 1,3-beta-glucan synthase component GLS2
- ATP-sensitive inward rectifier potassium channel 1
- Cytochrome P450 2C9
- Cytochrome P450 2D6 (2D6)
- Cytochrome P450 3A
- Inward rectifier potassium channel 2
- Inward rectifier potassium channel 4
- Renal Outer Medullary Potassium (ROMK)
- Sodium channel protein type 2 alpha subunit
- Voltage-gated calcium channel
| |
BDBM16294
 | 10 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | - Enoyl-ACP Reductase (FabI)
- Enoyl-ACP Reductase (InhA)
- Enoyl-ACP reductase (FabI1)
- Enoyl-ACP reductase (Wt ypFabV)
- Enoyl-ACP reductase T276S (T276S ypFabV)
- Enoyl-[acyl-carrier-protein] reductase [NADH] (ftuFabl)
| - 2PP
- 5-Ethyl-2-phenoxy-phenol
- 5-butyl-2-phenoxylphenol
- 5-ethyl-2-phenoxyphenol
- AIDS227443
- PT01
- US10071965, Compound PT04
|
BDBM16316
 | 1 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | - Inhibitor of nuclear factor kappa-B kinase subunit beta
- MAP kinase-activated protein kinase 2
- Mitogen-activated protein kinase 11
- Mitogen-activated protein kinase 14
- Protein kinase C alpha type
- Protein kinase C delta type
- Tyrosine-protein kinase JAK3
- Tyrosine-protein kinase Lck
- Tyrosine-protein kinase SYK
- Tyrosine-protein kinase ZAP-70
- Vascular endothelial growth factor receptor 2
- cAMP-dependent protein kinase (PKA)
| - 3-({4-[(2,2-dimethylpropyl)(methyl)amino]-6-(4-methyl-1,4-diazepan-1-yl)-1,3,5-triazin-2-yl}amino)-N-methoxy-4-methylbenzamide
- CHEMBL225088
- triaminotriazine aniline amide inhibitor, 1
|
BDBM170440
 | 6 | 7 | 0 | 0 | 0 | 0 |